Clemens Kratochwil - Concepedia

Author

Clemens Kratochwil

Also Known As

C Kratochwil, C. Kratochwil, Clemens Kratochwil, KRATOCHWIL CLEMENS, KRATOCHWIL Clemens, Kratochwil, Clemens, Mark W. Konijnenberg, Mathias Muehlhauser, Neal Shore

276

Publications

24.9K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg German Cancer Research Center National Center for Tumor Diseases German Center for Lung Research

About

Clemens Kratochwil is an author at Heidelberg University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	28	5K
2	Health Sciences	17	18	1.6K
3	Engineering	10	10	2.2K
4	Cell Biology	4	4	1.8K
5	Biomolecular Engineering	1	1	874

Clemens Kratochwil

124

Publications

21.3K

Citations

H-Index

Page 1

	Year	Citations
<sup>68</sup>Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer Clemens Kratochwil, Paul Flechsig, Thomas Lindner, Journal of Nuclear Medicine	2019	1.4K
<sup>225</sup>Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer Clemens Kratochwil, Frank Bruchertseifer, Frederik L. Giesel, Journal of Nuclear Medicine	2016	1K
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel, European Journal of Nuclear Medicine and Molecular Imaging	2014	966
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein Thomas Lindner, Anastasia Loktev, Annette Altmann, Journal of Nuclear Medicine EngineeringTumor BiologyTheranosticsFibroblast Growth FactorAnti-cancer Agent	2018	874
German Multicenter Study Investigating<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil, Journal of Nuclear Medicine	2016	812
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts Anastasia Loktev, Thomas Lindner, Walter Mier, Journal of Nuclear Medicine EngineeringOncologic ImagingPathologyCancer-associated FibroblastsTumor Biology	2018	729
<sup>68</sup>Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Journal of Nuclear Medicine	2018	674
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial Andreas Engert, Heinz Haverkamp, Carsten Kobe, The Lancet Lymphoid NeoplasiaRadiation TherapyMedicineHd15 TrialCancer Treatment	2012	621
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>177</sup>Lu-Labeled PSMA-617 Clemens Kratochwil, Frederik L. Giesel, M. Stefanova, Journal of Nuclear Medicine	2016	598
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer Martina Benešová, Martin Schäfer, Ulrike Bauder‐Wüst, Journal of Nuclear Medicine	2015	576

Page 1